Tetro Bio-Pharma enters subscription agreement following advice from Alpha Blue Ocean
Tetra Bio-Pharma Inc., a company working in cannabinoid-based drug discovery and development, has announced it…
August 12, 2022 - 2 minutes
FDA
First patient enrolled on Panbela’s trial for treatment of pancreatic cancer
Panbela Therapeutics, a U.S.-based clinical stage company, announced today (August 11) that it has enrolled…
August 11, 2022 - 3 minutes
Mersana Therapeutics announces collaboration with GSK for the co-development of cancer treatment
A global collaboration was announced today (August 9) between Mersana Therapeutics Inc and GSK plc…
August 9, 2022 - 3 minutes
Positive trial results for schizophrenia drug, KarTX, from PureTech’s founded entity, Karuna Therapeutics
Positive topline results from a phase 3 trial looking at the effect of a drug…
August 8, 2022 - 4 minutes
HUTCHMED drug in colorectal cancer trial meets primary endpoint
A trial to look at the use of a drug targeting refractory metastatic colorectal cancer…
August 8, 2022 - 3 minutes
Abivax has approval granted to enroll ulcerative colitis patients in two studies
Patients with moderate to severe ulcerative colitis (UC) can now be enrolled onto two phase…
August 5, 2022 - 3 minutes
First of its kind drug, to reverse effects of cocaine intoxication, awarded grant
An enzyme that efficiently degrades and metabolizes cocaine has been given a ‘cooperative agreement grant’…
August 4, 2022 - 3 minutes
Deal worth $3.7B sealed as Amgen buys biopharma ChemoCentryx
A company producing drugs including TAVNEOS to treat autoimmune diseases, plus others dealing with inflammatory…
August 4, 2022 - 3 minutes
PolyPid to receive millions for commercialization of infection-fighting drug
A drug to prevent surgical site infections (SSIs) in abdominal and cardiac surgeries in Europe…
August 4, 2022 - 3 minutes
Patients with advanced cancer set to benefit from ProfoundBio’s new drug
Patients with ovarian, endometrial, breast, non-small cell lung cancers and mesothelioma could benefit from an…
August 3, 2022 - 2 minutes
Full label approval given by FDA for eye disease drug, CIMERLI
Age-related neovascular (wet) macular degeneration (nAMD) and other serious retinal diseases can now be treated…
August 3, 2022 - 4 minutes
Ascletis announces FDA clearance of oral drug to conduct study in mild to moderate COVID-19 patients
A randomized, placebo-controlled study in mild to moderate COVID-19 patients has been approved by the…
August 3, 2022 - 2 minutes
